Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) currently represents one of the most common liver diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly asymptomatic, but can progress to nonalcoholic steatohepatitis (NASH) or cirrhosis or even lead to the development of hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gîlcă-Blanariu, Georgiana-Emmanuela, Budur, Daniela Simona, Mitrică, Dana Elena, Gologan, Elena, Timofte, Oana, Bălan, Gheorghe Gh, Olteanu, Vasile Andrei, Ștefănescu, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672868/
https://www.ncbi.nlm.nih.gov/pubmed/37999211
http://dx.doi.org/10.3390/metabo13111115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672868/
https://www.ncbi.nlm.nih.gov/pubmed/37999211
http://dx.doi.org/10.3390/metabo13111115

Ejemplares similares